Clinical Trial Update: Cardiovalve Transfemoral Mitral Valve System [NA]

View source ↗

Summary

A clinical trial evaluating the Cardiovalve Transfemoral Mitral Valve System for mitral regurgitation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Regurgitation

Drugs mentioned

• Cardiovalve Transfemoral Mitral Valve System

Snippet

Sponsor: Boston Biomedical Associates | Conditions: Mitral Regurgitation | NA | Status: TERMINATED